Nasal Cannulas: E Tumme Haholo Hona Joale Ka lebaka la COVID-19

Nasal cannula ke sesebelisoa sa bongaka se isang oksijene nkong. Moqapi oa eona o batla o le bonolo ho o hloekisa 'me o na le nako e telele ea bophelo haeba o hlokomeloa hantle. Li-cannula tsa nko li sebelisoa ho fana ka oksijene ha phallo e tlaase, e tlaase kapa e bohareng e hlokahala, 'me mokuli a le boemong bo tsitsitseng. Li-cannula tsa nko li sebelisa oksijene e phallang ka bongata le mokelikeli ho fa mokuli oksijene.

Phallo e phahameng ea li-cannula e otla khanyetso e itseng ho tsoa ho phallo ea phepelo, e bakang khatello e eketsehileng ea moea. Keketseho ena ea khatello ea moea e bonahala ho mohlala oa lesea le sa tsoa feta ntle le valve e fokotsang khatello. Ho qoba tšoaetso, bakuli ba lokela ho hloekisa tube ea cannula ka botlalo pele ba e sebelisa. Ho etsa bonnete ba hore cannula ha e na likokoana-hloko ebile ha e na libaktheria, e lokela ho hloekisoa ka asene e tšoeu le metsi a futhumetseng. Asene e bolaea libaktheria empa ha e je lintho tsa li-tubing. Joale, cannula e tlameha ho hlatsuoa ka metsi a batang ho tlosa sesepa le libaktheria. Joale, cannula e lokela ho omisoa pele e sebelisoa. Ho fetola li-cannula ho bohlokoa ho bakuli ba nang le maemo a phefumolohang.

Bakhanni ba Mmaraka:

Ho ata ho hoholo ha asthma ho lebelletsoe ho khothaletsa kholo ea 'maraka oa lefats'e oa cannula nakong ea kemiso. Mohlala, ho latela The Global Asthma Report 2018, ho ata ha matšoao a asthma e ne e le 23% mme ho ata ha tlhahlobo ea bongaka ea asthma ke 12% naheng ea Brazil.

Menyetla ea Mmaraka:

Keketseho ea bokhoni ba tlhahiso e lebelletsoe ho fana ka menyetla ea kholo ea kholo bakeng sa libapali 'marakeng oa lefats'e oa nasal cannula. Mohlala, ka Phuptjane 2020, Vapotherm, Inc. e ile ea holisa bokhoni ba eona ba ho etsa lisebelisoa tse kholo ho thusa k'hamphani ho eketsa tlhahiso ea lits'ebetso tsa eona tsa Precision Flow ka ho fihla ho 20X ka holimo ho maemo a seoa sa pele ho COVID-19.

Mekhoa ea Mmaraka:

Latin America e lebelletsoe ho paka kholo e kholo 'marakeng oa lefats'e oa cannula, ka lebaka la ho ata ha mafu a sa foleng a phekotso. Mohlala, ho latela Globocan 2018, Brazil e tlalehile linyeoe tse 559, 371 tsa mofets'e oa matšoafo ka 2018. Ho latela thuto ea 'Chronic Obstructive Pulmonary Disease in Latin America', e hatisitsoeng ka Pherekhong 2019 koranteng ea Annals of Global Health, ho ata ha lefu lena. COPD metseng ea Latin America e pakeng tsa 6.2 le 19.6% ho batho ba lilemo tse 40 ho ea holimo.

Ho hlaha ha Covid-19 ho lebisitse keketseho ea ho amoheloa ha cannula ea nko. Lefats'eng ka bophara, ho tloha ka 5:14pm CET, la 17 Tšitoe 2021, ho bile le linyeoe tse 271,963,258 tse netefalitsoeng tsa COVID-19, ho kenyeletsoa mafu a 5,331,019, a tlalehiloeng ho WHO. Ho tloha ka la 16 Tšitoe 2021, kakaretso ea liente tse 8,337,664,456 e se e fanoe.

Sebaka sa Tlholisano:

Libapali tse kholo tse sebetsang 'marakeng oa lefats'e oa li-nasal cannula li kenyelletsa, Lihlahisoa tsa Allied Healthcare, Besmed Health Business Corp., Drive Devilbiss International, Edward LifeSciences Corp., Fairmont Medical, Flexicare Medical, Medtronic plc., Maquet Holding BV & Co. KG , Medin Medical Innovations, Salter Labs, Sorin Group, Smiths Medical, Terumo Corporation, Teleflex Incorporated, Vapotherm Inc., le Well Lead Medical Co. Ltd.